Almac Group, a global CDMO, is planning to recruit 1,800 jobs across its global operations throughout the next three years.
These jobs include operational, supervisory and managerial roles across its business and offer opportunities for both graduates and experienced candidates alike. Positions are available immediately across 120 different job roles at its sites in the UK, Ireland, North America, Singapore, Japan and the Nordic region.
Throughout the past 18 months, the company has been providing support to more than 140 separate research projects for COVID-19 vaccines and treatments through a range of service areas.
The group has experienced continued growth in revenue and employee numbers annually over the past 15 years and with significant investment in expansion projects planned for the next three years, the company plans to increase its headcount to 8,000 across its 19 facilities globally.
With 100% of the Group’s profits reinvested into the business, the company has already committed to various significant expansion and improvement projects across its sites. These additional jobs will support this ongoing investment.
Alan Armstrong, Almac Group CEO, commented: “Almac’s mission is to “advance human health” and we are proud to be supporting so many global clients as they develop their life-saving treatment for patients in need.”
